 Company Valuation: How and When to Value Your Startup Friday, September 11, 2009 8:30am to 11:00am 8:30 - Registration and Continental Breakfast 9:00 - 11:00 - Presentation, Q&A & Networking Citizens Bank Gateway Center 3025 Chemical Road Plymouth Meeting, PA 19462 There is a gulf between the assessed value of a company by an entrepreneur with a clear vision of success, and an investor who looks for risks at every step. What is the correct value of your startup? In this seminar, an experienced panel of entrepreneurs, investors and dealmakers will discuss how and when to place a valuation on your company, including methods of technology valuation, alternatives to valuation, and different perspectives on risk and reward. Moderator: Maureen O’Leary, Ph.D., Program Director, BioStrategy Partners Panelists: Stephen Roth, Ph.D., President, Chief Executive Officer, Immune Control Jeffrey H. Nicholas, Chair of the Technology & Venture Finance Group,Fox Rothschild Scott K. Dessain, M.D., Ph.D., President & Chief Scientific Officer, Immunome, Inc. Chris Starr, VP of Investments / Founder, The MAG Fund / Ben Franklin Technology Partners Event scheduled: Sep 11 2009 |
 |
|||
Nurturing early-stage and emerging life science companies
